Tim Fugmann auf LinkedIn: Immuno-transcriptomic profiling of ...de.linkedin.com › posts › tim-fugmann-a _i...
de.linkedin.com
Andere Beiträge von Tim anzeigen. Profil für Tim Fugmann anzeigen. Tim Fugmann. Chief Scientific Officer and Co-Founder
LinkedIn: LinkedInのTim Fugmann: 4th TCR-based Therapies for Solid ...jp.linkedin.com › posts › tim-fugmann-a _4...
· Tim Fugmannさんの投稿. Tim Fugmannさんのプロフィールを表示. Tim Fugmann. Chief Scientific Officer and Co-Founder. 8ヶ月前. この投稿について報告 ...
Tim Fugmann no LinkedIn: MEK inhibition enhances presentation of ...mz.linkedin.com › posts › tim-fugmann-a _...
mz.linkedin.com
Publicação de Tim Fugmann. Ver perfil de Tim Fugmann · Tim Fugmann. Chief Scientific Officer and Co-Founder. 5 m. Denunciar esta publicação; Close menu. Certain ...
Tim Fugmann on LinkedIn: Workflow enabling deepscale ...sg.linkedin.com › posts › tim-fugmann-a _...
sg.linkedin.com
· Tim Fugmann's Post. View profile for Tim Fugmann. Tim Fugmann. Chief Scientific Officer and Co-Founder. 7mo. Report this post; Close menu. Great ...
Tim fugmanntim-fugmann.mabeya.de
tim-fugmann.mabeya.de
Tim fugmann. Tim Fugmann European Antibody Congres الويبTim Fugmann. Chief Scientific Officer and Co-Founder. 2w. Great study from Jenn Abelin and Steven ...
Alle Infos zum Namen "Tim Fugmann"
Data-Independent Acquisition of HLA Class I Europe PMCeuropepmc.org › article › med
europepmc.org
Conflicts of Interest: Dario Neri is co-founder of Philogen, shareholder and member of the board. Tim Fugmann and Danilo Ritz are employees of Philochem AG. The ...
Tim Fugmann on LinkedIn: Clonal replacement of tumor-specific T ...www.linkedin.com › posts › tim-fugmann-a
www.linkedin.com
Tim Fugmann's Post. View profile for Tim Fugmann · Tim Fugmann. Chief Scientific Officer and Co-Founder. 4y. Report this post; Close menu. PD1 checkpoint ...
Tim Fugmann on LinkedIn: Homewww.linkedin.com › posts › tim-fugmann-a
www.linkedin.com
· Tim Fugmann's Post. View profile for Tim Fugmann. Tim Fugmann. Chief Scientific Officer and Co-Founder. 10mo. Report this post; Close menu.
Tim Fugmann on LinkedIn: Perforin-2 is a pore-forming effector of ...www.linkedin.com › posts › tim-fugmann-a
www.linkedin.com
· Tim Fugmann's Post. View profile for Tim Fugmann. Tim Fugmann. Chief Scientific Officer and Co-Founder. 3mo. Report this post; Close menu. Cross ...
Tim Fugmann on LinkedIn: Philochem will be presenting at the ...www.linkedin.com › posts › tim-fugmann-a
www.linkedin.com
See other posts by Tim. View profile for Tim Fugmann. Tim Fugmann. Chief Scientific Officer and Co-Founder. 1mo.
Tim Fugmann on LinkedIn: Proteogenomic analysis reveals RNA as ...www.linkedin.com › posts › tim-fugmann-a
www.linkedin.com
Tim Fugmann's Post. View profile for Tim Fugmann. Tim Fugmann. Chief Scientific Officer and Co-Founder. 3w. Report this post; Close menu. There is growing ...
Tim Fugmann on LinkedIn: Restoring tumor immunogenicity with ...www.linkedin.com › posts › tim-fugmann-a
www.linkedin.com
Tim Fugmann's Post. View profile for Tim Fugmann. Tim Fugmann. Chief Scientific Officer and Co-Founder. 2w. Report this post; Close menu. Hot off the press: ...
New study linking expression of MHC complexes and response after ...www.linkedin.com › pulse › new-study-linking-exp...
www.linkedin.com
Close menu. Tim Fugmann. Tim Fugmann. Chief Scientific Officer and Co-Founder. Published Jul 19, + Follow. A study from the Dana Farber Cancer ...
Characterization of the Soluble HLA Peptidome for Predicting ...www.linkedin.com › pulse › characterization-solubl...
www.linkedin.com
Tim Fugmann. Chief Scientific Officer and Co-Founder. Published Jun 6, + Follow. We will be presenting our view on the prediction of response to ...
HLA peptidomes winning cover - LinkedInwww.linkedin.com › pulse › hla-peptidomes-winnin...
www.linkedin.com
Tim Fugmann. Chief Scientific Officer and Co-Founder. Published May 27, + Follow. We are proud to announce that our most recent publication on our ...
Natalie Clark, PhD posted on LinkedInwww.linkedin.com › posts
www.linkedin.com
· View profile for Tim Fugmann · Tim Fugmann. Chief Scientific Officer and Co-Founder. 9mo. Great study from Jenn Abelin and Steven Carr lab on ...
NecstGen on LinkedIn: Outsourcing Cell & Gene Therapy ...www.linkedin.com › posts › necstgen_outsourcing-c...
www.linkedin.com
· View profile for Tim Fugmann · Tim Fugmann. Chief Scientific Officer and Co-Founder. 3w. Report this post; Close menu. Discovery of #HLA ...
Alithea Bio UG's Post - growfast #gofar - LinkedInwww.linkedin.com › posts
www.linkedin.com
· View profile for Tim Fugmann · Tim Fugmann. Chief Scientific Officer and Co-Founder. 8mo. Looking forward to travelling to #boston, the #biotech ...
Anke Fuchs on LinkedIn: Looking forward to the endeavorwww.linkedin.com › posts
www.linkedin.com
· Tim Fugmann. Chief Scientific Officer and Co-Founder. 1y. Report this comment; Close menu. Congratulations and good luck Anke Fuchs ...
Josh Elias on LinkedIn: #teamsciencewww.linkedin.com › posts
www.linkedin.com
· Congrats, Josh! Like · Reply. 1 Reaction. Tim Fugmann. Chief Scientific Officer and Co-Founder. 4y. Report this comment; Close menu.
Immunotherapy awarded Nobel price - LinkedIn
www.linkedin.com
Tim Fugmann. Chief Scientific Office and Co-Founder. Published Oct 1, + Follow. James Allison and Tasuku Honjo awarded the Nobel price in Medicine for ... › pulse
sortiert nach Relevanz / Datum